IRIS Accounts Production v26.1.10.61 06796032 Board of Directors 1.11.24 31.10.25 31.10.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067960322024-10-31067960322025-10-31067960322024-11-012025-10-31067960322023-10-31067960322023-11-012024-10-31067960322024-10-3106796032ns15:EnglandWales2024-11-012025-10-3106796032ns14:PoundSterling2024-11-012025-10-3106796032ns10:Director12024-11-012025-10-3106796032ns10:PrivateLimitedCompanyLtd2024-11-012025-10-3106796032ns10:SmallEntities2024-11-012025-10-3106796032ns10:AuditExempt-NoAccountantsReport2024-11-012025-10-3106796032ns10:SmallCompaniesRegimeForDirectorsReport2024-11-012025-10-3106796032ns10:SmallCompaniesRegimeForAccounts2024-11-012025-10-3106796032ns10:FullAccounts2024-11-012025-10-310679603212024-11-012025-10-3106796032ns10:Director22024-11-012025-10-3106796032ns10:RegisteredOffice2024-11-012025-10-3106796032ns5:CurrentFinancialInstruments2025-10-3106796032ns5:CurrentFinancialInstruments2024-10-3106796032ns5:ShareCapital2025-10-3106796032ns5:ShareCapital2024-10-3106796032ns5:RetainedEarningsAccumulatedLosses2025-10-3106796032ns5:RetainedEarningsAccumulatedLosses2024-10-3106796032ns5:NetGoodwill2024-11-012025-10-3106796032ns5:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3106796032ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-11-012025-10-3106796032ns5:PlantMachinery2024-11-012025-10-3106796032ns5:FurnitureFittings2024-11-012025-10-3106796032ns5:NetGoodwill2024-10-3106796032ns5:NetGoodwill2025-10-3106796032ns5:NetGoodwill2024-10-3106796032ns5:LandBuildings2024-10-3106796032ns5:PlantMachinery2024-10-3106796032ns5:LandBuildings2024-11-012025-10-3106796032ns5:LandBuildings2025-10-3106796032ns5:PlantMachinery2025-10-3106796032ns5:LandBuildings2024-10-3106796032ns5:PlantMachinery2024-10-3106796032ns5:WithinOneYearns5:CurrentFinancialInstruments2025-10-3106796032ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-31
REGISTERED NUMBER: 06796032 (England and Wales)









Unaudited Financial Statements

for the Year Ended 31 October 2025

for

PHARMA-CLINIC LTD

PHARMA-CLINIC LTD (REGISTERED NUMBER: 06796032)






Contents of the Financial Statements
for the Year Ended 31 October 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PHARMA-CLINIC LTD

Company Information
for the Year Ended 31 October 2025







DIRECTORS: Mr T R Nawaz
Mr F H Qadir





REGISTERED OFFICE: 6 Knowle Green
Dore
South Yorkshire
S17 3AP





REGISTERED NUMBER: 06796032 (England and Wales)





ACCOUNTANTS: Brown McLeod Limited
Chartered Accountants
The Old Workshop
1 Ecclesall Road South
Sheffield
South Yorkshire
S11 9PA

PHARMA-CLINIC LTD (REGISTERED NUMBER: 06796032)

Balance Sheet
31 October 2025

31.10.25 31.10.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 434,197 358,639
Tangible assets 5 228,162 3,661
662,359 362,300

CURRENT ASSETS
Stocks 116,082 91,598
Debtors 6 282,843 274,947
Cash at bank 137,917 275,434
536,842 641,979
CREDITORS
Amounts falling due within one year 7 778,109 732,524
NET CURRENT LIABILITIES (241,267 ) (90,545 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

421,092

271,755

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 420,892 271,555
SHAREHOLDERS' FUNDS 421,092 271,755

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 April 2026 and were signed on its behalf by:



Mr T R Nawaz - Director


PHARMA-CLINIC LTD (REGISTERED NUMBER: 06796032)

Notes to the Financial Statements
for the Year Ended 31 October 2025

1. STATUTORY INFORMATION

Pharma-Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of fifteen years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - Nil depreciation
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PHARMA-CLINIC LTD (REGISTERED NUMBER: 06796032)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 November 2024 412,229
Additions 109,468
At 31 October 2025 521,697
AMORTISATION
At 1 November 2024 53,590
Charge for year 33,910
At 31 October 2025 87,500
NET BOOK VALUE
At 31 October 2025 434,197
At 31 October 2024 358,639

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 November 2024 - 16,107 16,107
Additions 224,810 529 225,339
At 31 October 2025 224,810 16,636 241,446
DEPRECIATION
At 1 November 2024 - 12,446 12,446
Charge for year - 838 838
At 31 October 2025 - 13,284 13,284
NET BOOK VALUE
At 31 October 2025 224,810 3,352 228,162
At 31 October 2024 - 3,661 3,661

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.25 31.10.24
£    £   
Trade debtors 240,222 213,909
Other debtors 42,621 61,038
282,843 274,947

PHARMA-CLINIC LTD (REGISTERED NUMBER: 06796032)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.25 31.10.24
£    £   
Trade creditors 380,969 272,983
Taxation and social security 71,233 51,050
Other creditors 325,907 408,491
778,109 732,524

8. ULTIMATE CONTROLLING PARTY

The controlling party is directors acting in concert.